The Efficacy of Using Quantitative HBs Antigen Levels in the Therapy of Patients with Hepatitis B Infectio

Not Applicable

• Conditions: Therapy of Chronic Hepatitis B virus infection; Infection - Studies of infection and infectious agents; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12612001299897
• Lead Sponsor: Gastroenterology Institute of Marmara University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-12-17
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Treatment-naive-hepatitis B virus infection patients for whom a treatment plan has been made by the hepatology outpatient clinic. (Indication for treatment is the presence of HBs Ag in serum for more than 6 months, and by liver biopsy showing histological features of chronic hepatitis compatible with HBV infection.)

Exclusion Criteria

- Prior antiviral therapy
- Immunosuppressive therapy within the previous 6 months
- Presence of viral coinfections,with hepatitis C, hepatitis D, or human immunodeficiency virus;
- Presence of other acquired or inherited causes of liver disease

Study & Design

• Study Type: Observational
• Study Design: Not specified